Show
Sort by
-
SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021
-
- Journal Article
- A1
- open access
Dynamics of SARS-CoV-2 IgG in nursing home residents in Belgium throughout three BNT162b2 vaccination rounds : 19-month follow-up
-
- Journal Article
- A1
- open access
SARS-CoV-2 seropositivity in nursing home staff and residents during the first SARS-CoV-2 wave in Flanders, Belgium
-
- Journal Article
- A2
- open access
Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium
-
- Journal Article
- A1
- open access
Follow-up of SARS-CoV-2 antibody levels in Belgian nursing home residents and staff two, four and six months after primary course BNT162b2 vaccination
-
- Journal Article
- A1
- open access
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign
-
- Journal Article
- A1
- open access
Vaccine hesitancy towards the COVID-19 vaccine in a random national sample of Belgian nursing home staff members
-
- Miscellaneous
- open access
SARS-CoV-2 seroprevalence among nursing home residents in March 2022 : brief communication on results of the scope-2 study (SARS-COV-2 seroprevalence)
(2022) -
- Journal Article
- A1
- open access
Declining prevalence of SARS-CoV-2 antibodies among vaccinated nursing home residents and staff six months after the primary BNT162b2 vaccination campaign in Belgium : a prospective cohort study
-
- Miscellaneous
- open access
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 1 : februari 2021
(2021)